A detailed history of Yhb Investment Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Yhb Investment Advisors, Inc. holds 5,926 shares of ABT stock, worth $697,845. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,926
Previous 6,455 8.2%
Holding current value
$697,845
Previous $670,000 0.75%
% of portfolio
0.06%
Previous 0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$100.07 - $118.13 $52,937 - $62,490
-529 Reduced 8.2%
5,926 $675,000
Q2 2024

Aug 01, 2024

SELL
$100.73 - $112.44 $39,687 - $44,301
-394 Reduced 5.75%
6,455 $670,000
Q1 2024

Aug 14, 2024

BUY
$109.52 - $120.96 $43,150 - $47,658
394 Added 6.1%
6,849 $778,000
Q1 2024

Apr 26, 2024

SELL
$109.52 - $120.96 $36,360 - $40,158
-332 Reduced 4.62%
6,849 $778,000
Q4 2023

Jan 29, 2024

SELL
$90.19 - $110.4 $2,254 - $2,760
-25 Reduced 0.35%
7,181 $790,000
Q2 2023

Aug 10, 2023

SELL
$100.78 - $112.29 $20,156 - $22,458
-200 Reduced 2.7%
7,206 $785,000
Q1 2023

May 08, 2023

SELL
$96.86 - $114.01 $2,905 - $3,420
-30 Reduced 0.4%
7,406 $749,000
Q4 2022

Jan 12, 2023

SELL
$95.06 - $111.52 $4,943 - $5,799
-52 Reduced 0.69%
7,436 $0
Q3 2022

Nov 03, 2022

BUY
$96.76 - $112.03 $43,542 - $50,413
450 Added 6.39%
7,488 $725,000
Q2 2022

Jul 14, 2022

BUY
$102.07 - $123.37 $20,414 - $24,674
200 Added 2.92%
7,038 $765,000
Q1 2022

Apr 14, 2022

SELL
$114.02 - $139.04 $1,710 - $2,085
-15 Reduced 0.22%
6,838 $809,000
Q4 2021

Jan 18, 2022

SELL
$115.53 - $141.46 $28,304 - $34,657
-245 Reduced 3.45%
6,853 $964,000
Q3 2021

Oct 28, 2021

BUY
$116.66 - $129.06 $1,516 - $1,677
13 Added 0.18%
7,098 $838,000
Q2 2021

Jul 15, 2021

BUY
$105.79 - $124.53 $8,463 - $9,962
80 Added 1.14%
7,085 $821,000
Q1 2021

Apr 22, 2021

SELL
$108.84 - $128.23 $10,339 - $12,181
-95 Reduced 1.34%
7,005 $871,000
Q4 2020

Jan 21, 2021

BUY
$105.0 - $114.42 $38,430 - $41,877
366 Added 5.44%
7,100 $777,000
Q3 2020

Nov 02, 2020

SELL
$91.64 - $111.29 $2.54 Million - $3.08 Million
-27,714 Reduced 80.45%
6,734 $733,000
Q1 2020

Apr 16, 2020

BUY
$62.82 - $91.86 $31,410 - $45,930
500 Added 1.47%
34,448 $2.72 Million
Q4 2019

Jan 27, 2020

SELL
$78.51 - $87.4 $23,553 - $26,220
-300 Reduced 0.88%
33,948 $2.95 Million
Q3 2019

Oct 15, 2019

BUY
$81.84 - $88.74 $8,184 - $8,874
100 Added 0.29%
34,248 $2.87 Million
Q2 2019

Jul 15, 2019

SELL
$72.88 - $85.0 $2,623 - $3,060
-36 Reduced 0.11%
34,148 $2.87 Million
Q1 2019

Apr 29, 2019

SELL
$66.22 - $80.06 $9,535 - $11,528
-144 Reduced 0.42%
34,184 $2.73 Million
Q4 2018

Jan 11, 2019

SELL
$65.56 - $74.27 $5,900 - $6,684
-90 Reduced 0.26%
34,328 $2.48 Million
Q2 2018

Jul 09, 2018

BUY
$57.57 - $63.54 $1.38 Million - $1.52 Million
23,974 Added 229.55%
34,418 $2.1 Million
Q1 2018

Apr 16, 2018

BUY
$56.27 - $63.62 $6,189 - $6,998
110 Added 1.06%
10,444 $626,000
Q4 2017

Jan 16, 2018

BUY
$53.68 - $57.47 $10,199 - $10,919
190 Added 1.87%
10,334 $590,000
Q3 2017

Nov 06, 2017

BUY
$48.06 - $53.64 $487,520 - $544,124
10,144
10,144 $541,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Yhb Investment Advisors, Inc. Portfolio

Follow Yhb Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yhb Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Yhb Investment Advisors, Inc. with notifications on news.